Tarceva.com treatment for non-small cell lung cancer and pancreatic cancer

Rating: 0 - 0 votes

Company Logo

Company Name

Company Contact

Website Analysis

Domain Whois

WHOIS information for Tarceva.com

Powered by who.is

Page Type

This page is about a company.

Title

Non-Small Cell Lung and Pancreatic Cancer: Tarceva.com

Description

Learn about non-small cell lung cancer, explore treatment options, and find resources. Tarceva (erlotinib) is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Tarceva is now approved in pancreatic cancer.